Variations in cell lines, timing post infection of NFκB assay and NFκB assay used, often varying widely from study to study, as well as the potential influence of the chlamydial protease CPAF, may all play a role in the inconsistent findings reported for C. trachomatis/NFκB studies. The gene discussed is NFKB1; the disease is infection.